Patent Yard Sign in
Expired Canadian patentCanada

Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus

CA 2450939 C · Owner: Inhibitex, Inc. · Inventors: Roche, Fiona; Foster, Timothy J.; Pallen, Mark

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Polyclonal and monoclonal antibodies which are cross-reactive to both coagulase-positive staphylococcus bacteria such as S. hemolyticus, are , provided which can recognize surface proteins from both coagulase-positive and coagulase negative staph bacteria. The antibodies may be generated from surface proteins that have been isolated on the basis of characteristics that may be common between S. aureus and coagulase-negative staphylococci and , these recombinant surface proteins are used to generate the antibodies of the invention. There is also provided vaccines and methods which utilize these proteins and antibodies for the treatment or protection against a wide variety of …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 17, 2002 and granted November 6, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 17, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 17, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 17, 2002
GrantedNovember 6, 2012
Term endedJune 17, 2022
Patent numberCA 2450939 C
Classification (IPC)C07K16/12 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJune 17, 2002Patent grantedNov 6, 2012Term endedJune 17, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.